The British Journal of Dermatology has published a feasibility study of microwave therapy for precancerous actinic keratosis (AK) using Emblation’s swift system. The clinical trial was carried out by researchers at the University of Dundee, and grant funded by Innovate UK.
The results of this study conclude that a significantly higher propotion of treated AK areas responded than untreated (90% vs 15%; P < 0.001). Thin AKs were more responsive than thick AKs. The site did not affect efficacy. Pain was severe, but brief (80% reported pain lasting 'a few seconds only'). Adverse events were minimal. All participants who would choose microwave therapy over their current treatment cited the shorter discomfort period.
Please follow this link to the full, open access paper – microwave therapy for AK.
Transforming the way microwave energy is used in healthcare and redefining the role medical devices play in the management of complex conditions.Find out more
Interested in using our patented platform technology for your clinical application?Find out more
Find out more about the award-winning Swift system-delivering breakthrough treatmentFind out more
Join our team
Join our award-winning team to be working on cutting edge medical breakthroughsFind out more